The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Atherectomy, Coronary

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Atherectomy, Coronary


High impact information on Atherectomy, Coronary


Chemical compound and disease context of Atherectomy, Coronary


Biological context of Atherectomy, Coronary


Anatomical context of Atherectomy, Coronary


Associations of Atherectomy, Coronary with chemical compounds


Gene context of Atherectomy, Coronary


Analytical, diagnostic and therapeutic context of Atherectomy, Coronary


  1. One hundred and thirteen attempts at directional coronary atherectomy: the early and combined experience of two European centres using quantitative angiography to assess their results. Umans, V., Haine, E., Renkin, J., de Feyter, P., Wijns, W., Serruys, P.W. Eur. Heart J. (1992) [Pubmed]
  2. Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris. Abe, J., Deguchi, J., Takuwa, Y., Hara, K., Ikari, Y., Tamura, T., Ohno, M., Kurokawa, K. Heart (1998) [Pubmed]
  3. Papillary endothelial hyperplasia in a TEC coronary atherectomy specimen. Crilley, J.G., Ritchie, C., de Belder, M.A. Heart (1997) [Pubmed]
  4. Relation of CD39 to plaque instability and thrombus formation in directional atherectomy specimens from patients with stable and unstable angina pectoris. Hatakeyama, K., Hao, H., Imamura, T., Ishikawa, T., Shibata, Y., Fujimura, Y., Eto, T., Asada, Y. Am. J. Cardiol. (2005) [Pubmed]
  5. Soluble P-selectin in human plasma: effect of anticoagulant matrix and its levels in patients with cardiovascular disorders. Amin, H.M., Ahmad, S., Walenga, J.M., Hoppensteadt, D.A., Leitz, H., Fareed, J. Clin. Appl. Thromb. Hemost. (2000) [Pubmed]
  6. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Laule, M., Cascorbi, I., Stangl, V., Bielecke, C., Wernecke, K.D., Mrozikiewicz, P.M., Felix, S.B., Roots, I., Baumann, G., Stangl, K. Lancet (1999) [Pubmed]
  7. Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Potter, D.D., Sobey, C.G., Tompkins, P.K., Rossen, J.D., Heistad, D.D. Circulation (1998) [Pubmed]
  8. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Hasdai, D., Holmes, D.R., Garratt, K.N., Edwards, W.D., Lerman, A. Circulation (1997) [Pubmed]
  9. Identification of active tissue factor in human coronary atheroma. Marmur, J.D., Thiruvikraman, S.V., Fyfe, B.S., Guha, A., Sharma, S.K., Ambrose, J.A., Fallon, J.T., Nemerson, Y., Taubman, M.B. Circulation (1996) [Pubmed]
  10. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Mintz, G.S., Popma, J.J., Pichard, A.D., Kent, K.M., Satler, L.F., Wong, C., Hong, M.K., Kovach, J.A., Leon, M.B. Circulation (1996) [Pubmed]
  11. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia. Hale, L.P., Smith, K., Braden, G.A., Owen, J. Catheterization and cardiovascular diagnosis. (1998) [Pubmed]
  12. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Mauri, L., Reisman, M., Buchbinder, M., Popma, J.J., Sharma, S.K., Cutlip, D.E., Ho, K.K., Prpic, R., Zimetbaum, P.J., Kuntz, R.E. Am. Heart J. (2003) [Pubmed]
  13. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. Matsuura, R., Isaka, N., Imanaka-Yoshida, K., Yoshida, T., Sakakura, T., Nakano, T. J. Pathol. (1996) [Pubmed]
  14. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Tsuchikane, E., Fukuhara, A., Kobayashi, T., Kirino, M., Yamasaki, K., Kobayashi, T., Izumi, M., Otsuji, S., Tateyama, H., Sakurai, M., Awata, N. Circulation (1999) [Pubmed]
  15. Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis. Increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Ozeki, S., Ohtsuru, A., Seto, S., Takeshita, S., Yano, H., Nakayama, T., Ito, M., Yokota, T., Nobuyoshi, M., Segre, G.V., Yamashita, S., Yano, K. Arterioscler. Thromb. Vasc. Biol. (1996) [Pubmed]
  16. Increased extracellular matrix synthesis by smooth-muscle cells obtained from in vivo restenotic lesions by directional coronary atherectomy. Violaris, A.G., de Jong, M., MacLeod, D.C., Umans, V.A., Verdouw, P.D., Serruys, P.W. Am. Heart J. (1996) [Pubmed]
  17. Novel use of a peripheral, self-expanding nitinol stent in adjunct to excimer laser coronary atherectomy in the treatment of degenerated vein graft disease. Gim, R.D., Bokhari, S.W., Winters, R.J. Reviews in cardiovascular medicine. (2005) [Pubmed]
  18. Restenosis after directional coronary atherectomy. Effects of luminal diameter and deep wall excision. Kuntz, R.E., Hinohara, T., Safian, R.D., Selmon, M.R., Simpson, J.B., Baim, D.S. Circulation (1992) [Pubmed]
  19. Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study. Lansky, A.J., Mintz, G.S., Popma, J.J., Pichard, A.D., Kent, K.M., Satler, L.F., Baim, D.S., Kuntz, R.E., Simonton, C., Bersin, R.M., Hinohara, T., Fitzgerald, P.J., Leon, M.B. J. Am. Coll. Cardiol. (1998) [Pubmed]
  20. Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial. Moliterno, D.J., Califf, R.M., Aguirre, F.V., Anderson, K., Sigmon, K.N., Weisman, H.F., Topol, E.J. Am. J. Cardiol. (1995) [Pubmed]
  21. Impact of cilostazol on intimal proliferation after directional coronary atherectomy. Tsuchikane, E., Katoh, O., Sumitsuji, S., Fukuhara, A., Funamoto, M., Otsuji, S., Tateyama, H., Awata, N., Kobayashi, T. Am. Heart J. (1998) [Pubmed]
  22. Effectiveness of tranilast on restenosis after directional coronary atherectomy. Kosuga, K., Tamai, H., Ueda, K., Hsu, Y.S., Ono, S., Tanaka, S., Doi, T., Myou-U, W., Motohara, S., Uehata, H. Am. Heart J. (1997) [Pubmed]
  23. Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Schoenhagen, P., Vince, D.G., Ziada, K.M., Kapadia, S.R., Lauer, M.A., Crowe, T.D., Nissen, S.E., Tuzcu, E.M. Am. J. Cardiol. (2002) [Pubmed]
  24. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis - novel targets for pharmacotherapy in atherosclerosis. Ihling, C., Bohrmann, B., Schaefer, H.E., Technau-Ihling, K., Loeffler, B.M. Current vascular pharmacology (2004) [Pubmed]
  25. Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Ejiri, J., Inoue, N., Kobayashi, S., Shiraki, R., Otsui, K., Honjo, T., Takahashi, M., Ohashi, Y., Ichikawa, S., Terashima, M., Mori, T., Awano, K., Shinke, T., Shite, J., Hirata, K., Yokozaki, H., Kawashima, S., Yokoyama, M. Circulation (2005) [Pubmed]
  26. Immunohistochemical analysis of hepatocyte growth factor in human coronary atherectomy specimens: comparison with transforming growth factor beta isoforms. Ueda, H., Imazu, M., Hayashi, Y., Ono, K., Yasui, W., Yamakido, M. Virchows Arch. (1997) [Pubmed]
  27. Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty. Hokimoto, S., Oike, Y., Saito, T., Kitaoka, M., Oshima, S., Noda, K., Moriyama, Y., Ishibashi, F., Ogawa, H. Circ. J. (2002) [Pubmed]
  28. Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. Koch, K.C., vom Dahl, J., Kleinhans, E., Klues, H.G., Radke, P.W., Ninnemann, S., Schulz, G., Buell, U., Hanrath, P. J. Am. Coll. Cardiol. (1999) [Pubmed]
  29. Quantitative angiography of coronary artery dimensions 24 hours after rotational atherectomy. Reisman, M., Buchbinder, M., Harms, V., McDaniel, M., Peterson, K.L. Am. J. Cardiol. (1998) [Pubmed]
  30. Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. Eisenberg, M.J., Califf, R.M., Cohen, E.A., Adelman, A.G., Mark, D.B., Topol, E.J. Am. J. Cardiol. (1997) [Pubmed]
  31. Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention. Denardo, S.J., Davis, K.E., Reid, P.R., Tcheng, J.E. Am. J. Cardiol. (2003) [Pubmed]
WikiGenes - Universities